검색어 : 통합검색[Booth Wayne]
총 393건 중 393건 출력
, 39/40 페이지
-
381
- Lead isotopes in ground and surface waters: fingerprinting heavy metal sources in mineral exploration
- Leybourne, Matthew I.; Cousens, Brian L.; Goodfellow, Wayne D.; GNS Science , P.O. Box 30-368, Lower Hutt, New Zealand; Ottawa-Carleton Geoscience Centre, Department of Earth Sciences, Carleton University , Ottawa, Ontario, K1S 5B6, Canada; Geological Survey of Canada , 601 Booth Street, Ottawa, Ontario, K1A 0E8, Canada; (Geochemistry : exploration, environment, analysis, v.9, 2009, pp.115-123)
-
382
- Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells
- Shridhar, Ravi; Zhang, Jun; Song, Jin; Booth, Blake A; Kevil, Christopher G; Sotiropoulou, Georgia; Sloane, Bonnie F; Keppler, Daniel; 1Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA; 2Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; 2Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; 3Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; [1] 3Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA [2] 4Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; 5Department of Pharmacy, University of Patras, Rion 26500, Patras, Greece; [1] 1Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA [2] 6Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA; [1] 1Department of Pharmacology, Wayne; (Oncogene, v.23, 2004, pp.2206-2215)
-
383
- Geochemistry of fluid phases and sediments: relevance to hydrothermal circulation in Middle Valley, ODP Legs 139 and 169
- Gieskes, Joris M; Simoneit, Bernd R.T; Shanks III, Wayne C; Goodfellow III, Wayne D; James III, Rachael H; Baker III, Paul A; Ishibashi III, Jun-ishiro; ; (Applied geochemistry : journal of the International Association of Geochemistry and Cosmochemistry, v.17, 2002, pp.1381-1399)
-
384
- Hydrothermal geochemistry of sediments and pore waters in Escanaba Trough—ODP Leg 169
- Gieskes, Joris M; Simoneit, Bernd R.T; Goodfellow, Wayne D; Baker, Paul A; Mahn, Chris; ; (Applied geochemistry : journal of the International Association of Geochemistry and Cosmochemistry, v.17, 2002, pp.1435-1456)
-
385
- Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-sectional exploratory study in healthy volunteers
- Lukacs, Jane L.; Booth, Sarah; Kleerekoper, Michael; Ansbacher, Rudi; Rock, Cheryl L.; Reame, Nancy E.; From the 1School of Nursing, University of Michigan, Ann Arbor, MI; 2Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA; 3Internal Medicine/Endocrinology and Obstetrics and Gynecology at Wayne State University, Detroit, MI; 4Obstetrics and Gynecology; 5Reproductive Sciences Program, University of Michigan, Ann Arbor, MI; and 6Family and Preventive Medicine, University of California, San Diego, La Jolla, CA.; (Menopause : journal of the North American Menopause Society, v.13, 2006, pp.799-808)
-
386
- A randomized controlled trial testing the efficacy of a brief cannabis universal prevention program among adolescents in primary care
- Walton, Maureen A.; Resko, Stella; Barry, Kristen L.; Chermack, Stephen T.; Zucker, Robert A.; Zimmerman, Marc A.; Booth, Brenda M.; Blow, Frederic C.; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Wayne State University School of Social Work and Merrill Palmer Skillman Institute, Detroit, MI, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; University of Michigan, School of Public Health, Ann Arbor, MI, USA; Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; (Addiction, v.109, 2014, pp.786-797)
-
387
- Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202
- Ruppert, Amy S.; Booth, Allison M.; Ding, Wei; Bartlett, Nancy L.; Brander, Danielle M.; Coutre, Steven; Brown, Jennifer R.; Nattam, Sreenivasa; Larson, Richard A.; Erba, Harry; Litzow, Mark; Owen, Carolyn; Kuzma, Charles S.; Abramson, Jeremy S.; Little, Richard F.; Smith, Scott E.; Stone, Richard M.; Byrd, John C.; Mandrekar, Sumithra J.; Woyach, Jennifer A.; Division of Hematology, the Ohio State University, Columbus, OH, USA; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA; Mayo Clinic, Rochester, MN, USA; Washington University School of Medicine, St. Louis, MO, USA; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA; Stanford University School of Medicine, Stanford, CA, USA; Dana Farber/Partners CancerCare, Boston, MA, USA; Fort Wayne Medical Oncology & Hematology, Fort Wayne, IN, USA; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA; Mayo Clinic, Rochester, MN, USA; University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada; First Health of the Carolinas Cancer Center, Pinehurst, NC, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, MD, USA; Loyola University Chicago, Chicago IL, USA; Dana Farber/Partn; (Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, v.35, 2021, pp.2854-2861)
-
388
- Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.
- Ruppert, Amy S.; Mandrekar, Sumithra J.; Booth, Allison M.; Ding, Wei; Bartlett, Nancy L.; Brander, Danielle M.; Coutre, Steve E.; Brown, Jennifer R.; Nattam, Sreenivasa R.; Larson, Richard A.; Erba, Harry Paul; Litzow, Mark Robert; Owen, Carolyn; Kuzma, Charles S.; Abramson, Jeremy S.; Little, Richard F.; Smith, Scott E.; Stone, Richard M.; Byrd, John C.; Woyach, Jennifer Ann; The Ohio State University, Department of Internal Medicine, Columbus, OH; ; Mayo Clinic, Rochester, MN; ; Mayo Clinic, Rochester, MN; ; Mayo Clinic, Rochester, MN; ; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO; ; Duke University School of Medicine, Durham, NC; ; Stanford University School of Medicine, Stanford, CA; ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; ; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN; ; University of Chicago, Chicago, IL; ; Duke University, Durham, NC; ; Mayo Clinic, Rochester, MN; ; Tom Baker Cancer Centre, Calgary, AB, Canada; ; First Health of the Carolinas Cancer Ctr, Pinehurst, NC; ; Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, MA; ; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; ; Loyola University Medical Center, Maywood, IL; ; Dana-Farber Cancer Institute, Boston, MA; ; The Ohio State University Compreh; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.38, 2020, pp.e20004-e20004)
-
389
- Long-Term Results of Alliance A041202 Show Continued Advantage of Ibrutinib-Based Regimens Compared with Bendamustine Plus Rituximab (BR) Chemoimmunotherapy
- Woyach, Jennifer A.; Ruppert, Amy S.; Heerema, Nyla A.; Zhao, Weiqiang; Booth, Allison M; Ding, Wei; Bartlett, Nancy L.; Brander, Danielle M.; Barr, Paul M.; Rogers, Kerry; Parikh, Sameer A.; Coutre, Steven; Lozanski, Gerard; Nattam, Sreenivasa; Larson, Richard A.; Erba, Harry P.; Litzow, Mark R.; Blachly, James S.; Owen, Carolyn; Kuzma, Charles; Abramson, Jeremy S.; Brown, Jennifer R; Little, Richard F.; Smith, Scott E.; Stone, Richard M.; Mandrekar, Sumithra J; Byrd, John C.; The Ohio State University, Columbus, OH; Division of Hematology, The Ohio State University, Columbus, OH; Department of Pathology, The Ohio State University, Columbus, OH; Department of Pathology, The Ohio State University, Columbus, OH; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Mayo Clinic, Rochester, MN; Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MO; Duke Cancer Institute, Duke University Medical Center, Durham, NC; University of Rochester, Rochester, NY; The Ohio State University, Columbus, OH; Hematology, Mayo Clinic, Rochester, MN; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA; Department of Pathology, The Ohio State University, Columbus, OH; Fort Wayne Oncology Hematology, Fort Wayne, IN; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; University of Alabama at Birmingham, Birmingham, AL; Division of Hematology, Mayo Clini; (Blood, v.138, 2021, pp.639-639)
-
390
- Ibrutinib Alone or in Combination with Rituximab Produces Superior Progression Free Survival (PFS) Compared with Bendamustine Plus Rituximab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL): Results of Alliance North American Intergroup Study A041202
- Woyach, Jennifer A.; Ruppert, Amy S.; Heerema, Nyla A.; Zhao, Weiqiang; Booth, Allison M; Ding, Wei; Bartlett, Nancy L.; Brander, Danielle M.; Barr, Paul; Rogers, Kerry A.; Parikh, Sameer A.; Coutre, Steven; Hurria, Arti; Lozanski, Gerard; Nattam, Sreenivasa; Larson, Richard A.; Erba, Harry P.; Litzow, Mark R.; Owen, Carolyn; Atkins, Jim; Abramson, Jeremy S.; Little, Richard F.; Smith, Scott E.; Stone, Richard M.; Mandrekar, Sumithra J; Byrd, John C.; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Columbus, OH; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Mayo Clinic, Rochester, MN; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO; Duke University Medical Center, Durham, NC; University of Rochester, Rochester, NY; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH; Division of Hematology, Mayo Clinic, Rochester, MN; Stanford University Medical Center, Stanford, CA; City of Hope, Duarte, CA; Department of Pathology, The Ohio State University, Columbus, OH; Fort Wayne Oncology Hematology, Fort Wayne, IN; University of Chicago Comprehensive Cancer Center, Chicago, IL; University of Alabama at Bi; (Blood, v.132, 2018, pp.6-6)
QUICK MENU
